Alpha 2.0
Login Register
» Authors » R L Ashare

R L Ashare

Explore the profile of R L Ashare including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 49
Followers 0
Related Specialties
Pharmacology
Public Health
Psychiatry
Top 10 Co-Authors
M R Hayes
H D Schmidt
B A Kimmey
M E Bowers
L E Rupprecht
K M Cummings
L W Hawk Jr
J C Gass
R J Herman
N J Schlienz
Published In
Transl Psychiatry
Clin Pharmacol Ther
Psychopharmacology (Berl)
Pharmacogenomics J
Affiliations
Soon will be listed here.
Recent Articles
1.
Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats
Herman R, Hayes M, Audrain-McGovern J, Ashare R, Schmidt H
Psychopharmacology (Berl) . 2023 May; 240(6):1373-1386. PMID: 37129617
Rationale: Nicotine cessation is associated with increased consumption of highly palatable foods and body weight gain in most smokers. Concerns about body weight gain are a major barrier to maintaining...
2.
Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers
Ashare R, Kimmey B, Rupprecht L, Bowers M, Hayes M, Schmidt H
Transl Psychiatry . 2017 Mar; 7(3):e1072. PMID: 28350399
No abstract available.
3.
Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers
Ashare R, Kimmey B, Rupprecht L, Bowers M, Hayes M, Schmidt H
Transl Psychiatry . 2016 Jan; 6:e713. PMID: 26784967
Tobacco smoking remains the leading cause of preventable death worldwide and current smoking cessation medications have limited efficacy. Thus, there is a clear need for translational research focused on identifying...
4.
APOE ɛ4, an Alzheimer's disease susceptibility allele, and smoking cessation
Ashare R, Karlawish J, Wileyto E, Pinto A, Lerman C
Pharmacogenomics J . 2012 Dec; 13(6):538-43. PMID: 23247396
Possessing an apolipoprotein E (APOE) ɛ4 allele, advanced age and smoking are risk factors for Alzheimer's disease and cognitive decline. Deficits in cognitive function also increase risk for smoking relapse....
5.
The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial
Hawk Jr L, Ashare R, Lohnes S, Schlienz N, Rhodes J, Tiffany S, et al.
Clin Pharmacol Ther . 2011 Dec; 91(2):172-80. PMID: 22130118
Preclinical research and learning theory suggest that a longer duration of varenicline treatment prior to the target quit date (TQD) would reduce smoking rates before cessation and improve abstinence outcomes....